Clinical Trials in Tennessee

Showing 2801-2820 of 9,675 trials

A Clinical Trial of BP1002 in Patients With Advanced Lymphoid Malignancies

NCT04072458

This study evaluates the safety, pharmacokinetics, and efficacy of BP1002 (L-Bcl-2) antisense oligonucleotide in patients with advanced lymphoid malignancies. Up to 12 evaluable patients with a diagnosis of relapsed or refractory lymphoid malignancies are expected to participate.

Mantle Cell LymphomaPeripheral T-cell Lymphoma (PTCL)Cutaneous T-cell Lymphoma (CTCL)+7 more

Bio-Path Holdings, Inc.30 participantsStarted Nov 2020

Augusta, Georgia, United States • Valhalla, New York, United States • Nashville, Tennessee, United States +2 more locations

TERMINATEDPhase 129 miles

Phase 1b/2 Study of TTI-101 in Combination for Patients With Metastatic Hormone Receptor-Positive and HER2-Negative Breast Cancer

NCT05384119

The primary objective of Phase 1b will be to evaluate the safety and tolerability of TTI-101 when added to palbociclib and AI or fulvestrant administered orally to participants with hormone receptor-positive (HR+) human epidermal receptor 2-negative (HER2)- palbociclib-resistant breast cancer, and to determine the recommended Phase 2 dose (RP2D) for TTI-101 when added to palbociclib and AI or fulvestrant. The primary objective of Phase 2 will be to evaluate anti-tumor activity in participants who receive TTI-101 added to palbociclib or ribociclib and AI or fulvestrant.

Breast Cancer

Tvardi Therapeutics, Incorporated6 participantsStarted Jan 2023

Fort Lauderdale, Florida, United States • St Louis, Missouri, United States • Nashville, Tennessee, United States +3 more locations

A Clinical Trial of BP1002 in Patients With Advanced Lymphoid Malignancies

Phase 1b/2 Study of TTI-101 in Combination for Patients With Metastatic Hormone Receptor-Positive and HER2-Negative Breast Cancer

Find Trials by Condition in Tennessee

Eye Movements in Visual Search

An Investigational Immunotherapy Study of BMS-986301 Alone or in Combination With Nivolumab, and Ipilimumab in Participants With Advanced Solid Cancers

Cognitive Behavioral Therapy and Real-Time Pain Management Intervention for Sickle Cell Via Mobile Applications

Milieu Teaching-AV (MT-AV Pilot)

FUnctional diagnoSIs of corONary Stenosis (FUSION)

Study to Determine the Efficacy and Safety of Romosozumab in the Treatment of Postmenopausal Women With Osteoporosis

A Phase 3 Randomized, Placebo-controlled Trial of Carboplatin and Paclitaxel With or Without Veliparib (ABT-888) in HER2-negative Metastatic or Locally Advanced Unresectable BRCA-associated Breast Cancer

[Study Evaluating the Efficacy and Safety of a Digital Therapeutic as an Adjunct to TAU in Postpartum Depression]

Trial to Assess Safety and Efficacy of MOR202 in Anti-PLA2R + Membranous Nephropathy (aMN)

Quaratusugene Ozeplasmid (Reqorsa) in Combination With Pembrolizumab in Previously Treated Non-Small Lung Cancer

Advancing Understanding of Transportation Options

Persona Partial Knee Clinical Outcomes Study

A Phase 1b Study of Imvotamab in Moderate to Severe Rheumatoid Arthritis

BioProtect Balloon Implant™ Balloon System Pivotal Study BP-007

Communication During Hospitalization About Resuscitation Trial

Guideline Directed Medical Therapy (GDMT) Optimization and Adherence Longitudinal Study for Heart Failure.

Living WELL: A Web-Based Program for Ovarian Cancer Survivors

Long-term Follow-up of Participants With Cerebral Adrenoleukodystrophy Who Were Treated With Lenti-D Drug Product